Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lundqvist

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Physics in Medicine and Biology|February 24, 2005
Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECTMattias Sandström, Vladimir Tolmachev, Kalevi Kairemo, et al.
Oncology Reports|June 21, 2006
Cellular processing in the SW1222 cell line of mAb A33 directly and indirectly radiohalogenatedJohanna Höglund, Anna Orlova, Anders Sundin, et al.
Medical Physics|February 21, 2006
Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapyShirin A Enger, Arash Rezaei, Per Munck af Rosenschöld, et al.
Medical Physics|March 15, 2006
Monte Carlo calculations of thermal neutron capture in gadolinium: a comparison of GEANT4 and MCNP with measurementsShirin A Enger, Per Munck af Rosenschöld, Arash Rezaei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particlesLars Gedda, Amelie Fondell, Hans Lundqvist, et al.
International Journal of Oncology|April 17, 2018
Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapyAnja C Mortensen, Diana Spiegelberg, Anna-Karin Haylock, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 10, 2008
Targeting CD44v6 expressed in head and neck squamous cell carcinoma: preclinical characterization of an 111In-labeled monoclonal antibodyKarl Sandström, Marika Nestor, Tomas Ekberg, et al.
Anticancer Research|March 2, 2005
Targeting against epidermal growth factor receptors. Cellular processing of astatinated EGF after binding to cultured carcinoma cellsAnna Orlova, Anna Sjöstrom, Ondrej Lebeda, et al.
Lakartidningen|April 2, 2004
[Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use]Hans Lundqvist, Jörgen Carlsson, Lars Gedda, et al.
Anticancer Research|April 20, 2006
Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI)Anna Orlova, Alexander Bruskin, Igor Sivaev, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Physics in Medicine and Biology|February 24, 2005
Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECTMattias Sandström, Vladimir Tolmachev, Kalevi Kairemo, et al.
Oncology Reports|June 21, 2006
Cellular processing in the SW1222 cell line of mAb A33 directly and indirectly radiohalogenatedJohanna Höglund, Anna Orlova, Anders Sundin, et al.
Medical Physics|February 21, 2006
Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapyShirin A Enger, Arash Rezaei, Per Munck af Rosenschöld, et al.
Medical Physics|March 15, 2006
Monte Carlo calculations of thermal neutron capture in gadolinium: a comparison of GEANT4 and MCNP with measurementsShirin A Enger, Per Munck af Rosenschöld, Arash Rezaei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2012
Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particlesLars Gedda, Amelie Fondell, Hans Lundqvist, et al.
International Journal of Oncology|April 17, 2018
Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapyAnja C Mortensen, Diana Spiegelberg, Anna-Karin Haylock, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 10, 2008
Targeting CD44v6 expressed in head and neck squamous cell carcinoma: preclinical characterization of an 111In-labeled monoclonal antibodyKarl Sandström, Marika Nestor, Tomas Ekberg, et al.
Anticancer Research|March 2, 2005
Targeting against epidermal growth factor receptors. Cellular processing of astatinated EGF after binding to cultured carcinoma cellsAnna Orlova, Anna Sjöstrom, Ondrej Lebeda, et al.
Lakartidningen|April 2, 2004
[Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use]Hans Lundqvist, Jörgen Carlsson, Lars Gedda, et al.
Anticancer Research|April 20, 2006
Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iodo-decahydro-closo-dodecaborate (iodo-DABI)Anna Orlova, Alexander Bruskin, Igor Sivaev, et al.
Pageof 5